Company Filing History:
Years Active: 2014-2023
Title: Richard Ryan Preston: Innovator in Antibody Technology
Introduction
Richard Ryan Preston is a notable inventor based in Escondido, California. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. With a total of 2 patents to his name, Preston's work has the potential to impact various medical applications.
Latest Patents
Preston's latest patents include groundbreaking inventions in the realm of mutant antibodies and multifunctional antibody conjugates. The first patent, titled "Mutant antibodies and conjugation thereof," describes a polypeptide that comprises seven β-strands and a first α-helix. This invention focuses on the structural arrangement of these strands to form an Ig domain, which is crucial for antibody functionality. The second patent, "Multifunctional antibody conjugates," details a novel approach to creating antibody conjugates that include a light chain constant kappa region and a biologically compatible linker. This innovation aims to enhance the efficacy of antibody-based therapies.
Career Highlights
Throughout his career, Richard Ryan Preston has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Covx Technologies and Pfizer Healthcare, where he contributed to the advancement of antibody technologies. His experience in these organizations has equipped him with the knowledge and skills necessary to innovate in this competitive field.
Collaborations
Preston has collaborated with several professionals in the industry, including Abhijit Suresh Bhat and Olivier Alexandre Laurent. These collaborations have likely fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Richard Ryan Preston is a distinguished inventor whose work in antibody technology is paving the way for future advancements in biotechnology. His patents reflect a commitment to innovation and a desire to improve therapeutic options for patients.